Predictive data to preserve health
Delivering and exploiting data for cardiac decompensation prevention
Trusted by clinical, academic and innovation partners
CHU Caen Normandie
inserm
Lyonbiopole
Medicalps
Heart Failure Deterioration Is Detected Too Late
Keep Patient at Home
Delay Loss of Autonomy
Reduce Avoidable Hospitalizations
64 MILLION
People living with
Heart Failure
1 in 5
adults aged 70–85
Hospitalization each year
Healthcare cost - expected to double by 2030
Continuous Cardiac Monitoring at Home
Subcutaneous sensing, AI prediction, clinical action, and patient stability in one seamless workflow.
Subcutaneous Sensor
Continuous capture of ECG, SCG, and temperature.
Small implant • passive daily monitoring
AI Pressure Estimation
Algorithms convert physiological signals into intracardiac pressure estimates.
Early decompensation detection
Clinical Decision Support
Clinicians identify high-risk patients and optimize intervention timing.
Risk triage • treatment optimization
Patient Stability
Simple status guidance supports safe self-management at home.
Stable • Monitor • Alert
Predict deterioration up to 30 days before hospitalization
Discover more about
Our Technology | Clinical Evidence
Benefits for All Actors
Early data. Targeted actions. Streamlined journey.
Patient
Healthcare
Shorter initial hospitalization
Earlier optimization of at-home treatment.
Reduced mental burden
Automated monitoring and structured reminders.
Fewer exacerbations, fewer readmissions
Early, data-driven adjustments.
Patients empowered in their own care
Integrated therapeutic education.
Improved clinical effectiveness
Early, actionable data.
Risk-based patient prioritization
Better resource allocation, less wasted time.
Enhanced productivity
Reliable data, available every day.
Simplified deployment
Clear pathway, phased integration.
Coming Soon
We are about to launch our first human trial in partnership with the Caen hospital (Normandy, France).